QuidelOrtho Corporation QDEL Current maturities of long-term debt

Current maturities of long-term debt at other companies

Bio-Rad LaboratoriesBIO

——

Opko HealthOPK

——

Labcorp HoldingsLH

——

Charles River LaboratoriesCRL

——

Personalis, Inc.PSNL

——

ZoetisZTS

——

Other financials

Income statement

See full

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

See full

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Cash flow

See full

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

See full

Market cap$832.61M-51.4%

Enterprise value$3.8B-20.1%

P/S0.3×-0.3×

Profitability

See full

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

See full

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is QuidelOrtho Corporation's current maturities of long-term debt?: QuidelOrtho Corporation (QDEL) reported current maturities of long-term debt of $0 in Q1 2026.